Results 201 to 210 of about 213,106 (383)
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi+3 more
wiley +1 more source
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley +1 more source
Anaemia and renal dysfunction are independently associated with BNP and NT‐proBNP levels in patients with heart failure [PDF]
Jochem Hogenhuis+6 more
openalex +1 more source
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer+25 more
wiley +1 more source
Left atrial enlargement and NT‐proBNP as predictors of sudden cardiac death in patients with heart failure [PDF]
Antoni Bayés‐Genís+18 more
openalex +1 more source
Association between anaemia and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP): Findings from the Heart and Soul Study [PDF]
Arati Desai+5 more
openalex +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad+9 more
wiley +1 more source
The relation between electrocardiographic ST-T changes and NT-proBNP in patients with acute ischemic stroke [PDF]
Jesper K. Jensen+5 more
openalex +1 more source